Rhumbline Advisers Accelerate Diagnostics, Inc Put Options Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AXDX
# of Institutions
3Shares Held
549KCall Options Held
0Put Options Held
0About Accelerate Diagnostics, Inc
- Ticker AXDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 99,059,904
- Market Cap $168M
- Description
- Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...